We are live on ! Find out more
BIVV

Bioverativ Inc. Common Stock
BIVV

Delisted

BIVV was delisted on the 8th of March, 2018.

Back to rankings

2 hedge funds and large institutions have $27K invested in Bioverativ Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 449 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 459 → 2 (-457)

100% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 449

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

100% less capital invested

Capital invested by funds: $5.76B → $27K (-$5.76B)

Holders
2
Holders Change
-457
Holders Change %
-99.56%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
449
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ACS
Archford Capital Strategies
Illinois
+$2.28K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$585M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$497M
3
Primecap Management
Primecap Management
California
-$411M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$274M
5
State Street
State Street
Massachusetts
-$232M
Name Holding Trade Value Shares
Change 		Change in
Stake
Arrowstreet Capital
26
Arrowstreet Capital
Massachusetts
– -$60M -1,112,134 Closed
CCM
27
Camber Capital Management
Massachusetts
– -$59.1M -1,096,000 Closed
Prudential Financial
28
Prudential Financial
New Jersey
– -$55M -1,019,132 Closed
Geode Capital Management
29
Geode Capital Management
Massachusetts
– -$52.3M -969,103 Closed
JP Morgan Chase
30
JP Morgan Chase
New York
– -$51.7M -958,676 Closed
AA
31
AQR Arbitrage
Connecticut
– -$49.9M -924,878 Closed
Two Sigma Advisers
32
Two Sigma Advisers
New York
– -$49.3M -913,778 Closed
Northern Trust
33
Northern Trust
Illinois
– -$47.6M -882,259 Closed
Westfield Capital Management
34
Westfield Capital Management
Massachusetts
– -$46.6M -864,275 Closed
APG Asset Management
35
APG Asset Management
Netherlands
– -$35M -780,100 Closed
First Trust Advisors
36
First Trust Advisors
Illinois
– -$41.4M -767,277 Closed
Dimensional Fund Advisors
37
Dimensional Fund Advisors
Texas
– -$40.9M -757,928 Closed
Ameriprise
38
Ameriprise
Minnesota
– -$31.6M -586,238 Closed
SEI Investments
39
SEI Investments
Pennsylvania
– -$29.6M -548,893 Closed
Russell Investments Group
40
Russell Investments Group
United Kingdom
– -$26.8M -496,386 Closed
Los Angeles Capital Management
41
Los Angeles Capital Management
California
– -$26.3M -488,370 Closed
Franklin Resources
42
Franklin Resources
California
– -$25.2M -467,789 Closed
Legal & General Group
43
Legal & General Group
United Kingdom
– -$25M -462,996 Closed
Principal Financial Group
44
Principal Financial Group
Iowa
– -$24.9M -461,103 Closed
Bank of America
45
Bank of America
North Carolina
– -$24.4M -452,808 Closed
SIM
46
Spark Investment Management
New York
– -$24.1M -446,100 Closed
MWNA
47
Marshall Wace North America
New York
– -$23.3M -431,619 Closed
PIM
48
Provident Investment Management
Michigan
– -$23.2M -430,732 Closed
N
49
Nuveen
North Carolina
– -$23.2M -430,000 Closed
Allianz Asset Management
50
Allianz Asset Management
Germany
– -$22.2M -411,187 Closed
1
2
3 4 5

BIVV Hedge Fund Activity: Q1 2018 in Review

2 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Bioverativ Inc. Common Stock (BIVV) for Q1 2018, worth a combined $27K — down 100% from $5.76B a quarter earlier.

Sellers outnumbered buyers: 449 funds closed out of BIVV and 1 opened new positions — a net loss of 448 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was Archford Capital Strategies, opening a new position worth an estimated $2.28K. The largest seller was BlackRock, exiting entirely with an estimated $585M sold.

  • 2 institutional investors held Bioverativ Inc. Common Stock (BIVV) as of Q1 2018, down from 459 in Q4 2017.
  • Funds reported $27K of Bioverativ Inc. Common Stock stock for Q1 2018, down 100% quarter-over-quarter.
  • 1 fund opened new Bioverativ Inc. Common Stock positions in Q1 2018 and 449 closed out, a net change of -448 holders.
  • The largest Bioverativ Inc. Common Stock buyer in Q1 2018 was Archford Capital Strategies, an estimated $2.28K added.
  • The largest Bioverativ Inc. Common Stock seller in Q1 2018 was BlackRock, an estimated $585M sold.

Based on aggregated 13F filings for Q1 2018.